Navigation Links
Michael J. Fox Foundation awards up to $3 million to industry teams
Date:1/31/2008

NEW YORK, NY, JANUARY 31, 2008. As part of its ongoing efforts to do whatever it takes to speed delivery of transformative treatments and a cure for Parkinson's disease, The Michael J. Fox Foundation for Parkinson's Research has awarded up to $3 million in total funding to four industry teams seeking to push potential new PD treatments closer to the clinic. The awards were granted under MJFF's Therapeutics Development Initiative (TDI) program. Open exclusively to industry researchers, TDI is the cornerstone of the Foundation's efforts to expand industry investment in PD drug development. Through TDI, the Foundation shares the risk of drug development, thus helping to speed companies abilities to reach critical decision points for Parkinson's disease projects. Each of the four TDI grant awardees listed below will undertake research aimed at solving critical gaps in the development of new PD treatments.

"While industry plays a vital role in shepherding new therapeutics through the development process toward clinical trials and patients, competitive pressures and tough allocation decisions too often get in the way of making the kinds of 'big bets' necessary for breakthrough developments" said Katie Hood, CEO of The Michael J. Fox Foundation. "By funding industry partners directly, TDI seeks to advance promising treatments that might otherwise get stuck at the pre-clinical stage. Our capital may be comparatively modest, but it can serve as a 'carrot' to leverage companies expertise and infrastructure and speed the development of therapeutics that could have an immense impact on patients' quality of life."

While the Foundation has funded industry researchers since its inception, the Therapeutics Development Initiative was launched in 2006 as part of a larger initiative to capture the attention and imagination of company decision-makers and encourage them to allocate resources to Parkinson's projects. To date, of the approximately $21 million t
'/>"/>

Contact: Dana Barde
dbarden@michaeljfox.org
212-509-0995
The Michael J. Fox Foundation for Parkinson's Research
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Intel Co-Founder Andrew S. Grove Dedicates Portion of His Estate, Up to $40 Million, to Michael J. Fox Foundation
2. Michael J. Fox Foundation Commits up to $3.8 Million to Develop Gene Silencing Neuroprotective Treatment for Parkinsons Disease
3. YOU: Staying Young Fourth New York Times Best-Seller for RealAge Test Creator Dr. Michael Roizen!
4. Katie Hood Appointed Chief Executive Officer of The Michael J. Fox Foundation
5. Siemens Medical Solutions Michael Long Recognized as one of Computerworlds 2008 Premier 100 IT Leaders
6. Michael J. Fox Foundation Launches Rapid Response Innovation Awards 2008 Following Strong Inaugural Year Response
7. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
8. Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
9. BioSeek Appoints Michael C. Venuti, Ph.D., Chief Executive Officer
10. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
11. Michael J. Fox Foundation Commits Up to $2 Million for PD Drug Development Under Target Validation 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Nplate(R) Data From MDS Studies Presented at ASH 2Nplate(R) Data From MDS Studies Presented at ASH 3Nplate(R) Data From MDS Studies Presented at ASH 4Nplate(R) Data From MDS Studies Presented at ASH 5Nplate(R) Data From MDS Studies Presented at ASH 6Nplate(R) Data From MDS Studies Presented at ASH 7Nplate(R) Data From MDS Studies Presented at ASH 8Nplate(R) Data From MDS Studies Presented at ASH 9Nplate(R) Data From MDS Studies Presented at ASH 10NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 2NHLBI Grant Awarded to Wake Forest, Pitt to Improve Banked Blood 3Discover Health Through Awareness 2Discover Health Through Awareness 3Caliper Life Sciences to Present at UBS Global Life Sciences Conference 56476 1Kidz Med Inc Receives Follow Up Purchase Order Leading to Highest Revenue Week at Beginning of Cold and Flu Season 56474 1Kidz Med Inc Receives Follow Up Purchase Order Leading to Highest Revenue Week at Beginning of Cold and Flu Season 56474 2Kidz Med Inc Receives Follow Up Purchase Order Leading to Highest Revenue Week at Beginning of Cold and Flu Season 56474 3Injury Research and Health Organizations Urge Congress to Save Lives and Money by Including Injury Prevention in Health Care Reform 56472 1Injury Research and Health Organizations Urge Congress to Save Lives and Money by Including Injury Prevention in Health Care Reform 56472 2Injury Research and Health Organizations Urge Congress to Save Lives and Money by Including Injury Prevention in Health Care Reform 56472 3